Value Deepens for Medtech Stocks
Results from Johnson & Johnson and Abbott Laboratories foreshadow good news for MedTech investors. Both companies outperformed on the top and bottom lines, driven by broad strength in their MedTech units.
Based on procedure volume data and the outlook for procedure growth, both companies should continue producing solid results over the next few years, which goes for the industry at large. Because the MedTech stocks are beaten up with a chance of outperforming consensus estimates, and many are trading at significant or critical support levels, a reversal looks imminent for the MedTech market.
TEXT 'MarketBeat' to 68285 to get FREE SMS breaking news alerts for the stocks that matter most to you. OR click here: https://www.marketbeat.com/arnreports...
The Value Deepens for Medtech Stocks: Reversal Imminent: https://www.marketbeat.com/originals/...
#stockstobuy #medtech #medtechstocks #johnsonandjohnson #abbottlaboratories #stryker #medtronic #stockstobuyorsell #stockmarketnewstoday #stocksectors #stockcharts #stockmarketexplained